• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, April 6, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study reveals large differences in drug prescriptions for newborns between NICUs

Bioengineer by Bioengineer
April 23, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Little is known concerning how extensively drugs are prescribed to newborns in different neonatal intensive care units (NICUs). A new British Journal of Clinical Pharmacology study of nearly 1,500 newborns admitted during 12 months to four different NICUs in The Netherlands found that drug use varies widely.

Cardiovascular and nervous system drugs were most often prescribed off-label in relation to newborns' age, and their prescription was highly variable between NICUs.

"These differences became larger with decreasing postmenstrual age although the proportion of off-label prescriptions in relation to neonatal age decreased," said lead author Dr. Robert Flint, of Erasmus Medical Center – Sophia Children's Hospital in The Netherlands.

The findings indicate that drug research in newborns should have high priority to ensure the use of safe and appropriate drug therapy in such young patients.

###

Media Contact

Josh Glickman
[email protected]

http://newsroom.wiley.com/

http://dx.doi.org/10.1111/bcp.13563

Share12Tweet7Share2ShareShareShare1

Related Posts

Spp1 Key to Bushy Cells in Hearing Loss

April 6, 2026

Single Molecule Model Unveils V-ATPase Role in Blastocyst

April 6, 2026

Frailty, Nutrition, Depression Impact Elderly Quality of Life

April 5, 2026

Real-World Safety of Second-Line Diabetes Drugs in Elderly

April 4, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    97 shares
    Share 39 Tweet 24
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1009 shares
    Share 399 Tweet 249
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Spp1 Key to Bushy Cells in Hearing Loss

Inkjet Printers Now Capable of Producing Structural Colors

Smart System Enhances Skin Cancer Detection Accuracy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.